Skip to content

Relaxin Measurement in Different Endometrial Preparation Approaches for Frozen Embryo Transfer

Relaxin Measurement in Different Endometrial Preparation Approaches for Frozen Embryo Transfer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06526520
Enrollment
5
Registered
2024-07-29
Start date
2024-08-01
Completion date
2026-12-31
Last updated
2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Frozen Embryo Transfer

Keywords

frozen embryo transfer, hormonal replacement cycle, natural cycle, Relaxin

Brief summary

To investigate the levels of Relaxin in different types of endometrial preparation for a frozen embryo transfer cycle. Up to now it is unclear, whether ovulation with a functional corpus luteum (CL) will be present in a natural proliferative phase (NPP) endometrial preparation approach.

Detailed description

The last years have seen a distinct shift from fresh (fresh ET) to frozen embryo transfer (FET) cycles. Furthermore it became obvious, that the endometrial preparation approach has a significant impact on the course of the pregnancy and that a HRT endometrial preparation approach is associated with a higher risk for bleeding and miscarriages in early pregnancy and for the development of pregnancy induced hypertension and pre-eclampsia later in pregnancy. These conditions are attributed to the absence of a CL in the HRT approach. Lately a new endometrial preparation approach is discussed and performed, the so called natural proliferative phase protocol, in which the follicle growth is monitored and when the lining is deemed to have a sufficient thickness and the triple lining pattern, exogeneous progesterone is started to induce secretory transformation before spontaneous ovulation. Despite some studies showing, that exogeneous progesterone administration might induce ovulation, it is not clear whether there will be a CL, producing Relaxin, in the NPP approach.

Interventions

DRUGExposure to progesterone or HRT medication

to add either progesterone only in the NPP protocol or E2 and progesterone in a HRT protocol

Sponsors

ART Fertility Clinics LLC
Lead SponsorOTHER

Study design

Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* regular menstrual cycles

Exclusion criteria

* abnormal findings of the ovaries (e.g endometriosis) * Intake of any hormones within 3 months of study start * desire to become pregnant

Design outcomes

Primary

MeasureTime frameDescription
Relaxin measurement4 to 6 monthsMeasurement of Relaxin in the different types of frozen embryo transfer

Countries

United Arab Emirates

Contacts

CONTACTBarbara Lawrenz, M.D. PhD
barbara.lawrenz@artfertilityclinics.com800 337845489
CONTACTJonalyn Edades, MBA
jonalyn.edades@artfertilityclinics.com800 337845489
PRINCIPAL_INVESTIGATORBarbara Lawrenz, PhD

ART Fertility Clinic

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 12, 2026